HOME >> BIOLOGY >> NEWS
Economic realities depleting arsenal of antiparasitic drugs

While resistance may be reducing the effectiveness of our medicine chest, we have another force to fear: economics. Many drugs still effective against parasitic diseases are either no longer available, no longer manufactured or in danger of being pulled from the market simply because they are not economically viable, say researchers from the Baylor College of Medicine and Centers for Disease Control and Prevention (CDC) at a presentation during the annual meeting of the American Society of Tropical Medicine and Hygiene.

"Parasites are a very common causes of disease in the world but because there is no market for antiparasitic drugs, drug companies are discontinuing production," says Clinton White of the Baylor College of Medicine in Houston.

By the phrase "no market" Dr. White does not mean that parasites do not cause signficant disease, but that these diseases are most commonly found in developing countries that do not have the money to effectively support production of these drugs. In addition, many drugs that are available overseas are used to treat infections that are only found occasionally in the United States making them prohibitively expensive to continue domestic production despite their necessity for a small population of Americans. Dr. White and his colleague Anne Moore from CDC first began looking into this phenomenon last summer when a number of clinicians noticed that they were having a hard time acquiring the drug praziquantel which is used to treat schistosomiasis, a parasitic disease that can cause chronic liver damage and affects an estimated 200 million people worldwide. The drug's manufacturer had simply stopped making it in the United States because it was losing money.

"Here we had a perfectly treatable infection and no access to a drug to treat it in this country," says White. The maker of praziquantel has since agreed to resume production, but White and Moore have found numerous similar instances where effective dr
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
29-Oct-2000


Page: 1 2 3

Related biology news :

1. Economic costs of extreme weather, state by state
2. Economic model to aid alligator farmers
3. Multi Drug Resistant-TB: Russian Economic Collapse Will Lead To Global Spread Of "Ebola With Wings"
4. Can The Economic Promise Of Drug Discovery Continue To Preserve The Suriname Forest?
5. Good Ergonomics Is Good Economics
6. Penn State Eries Sea Grant To Focus On Ecology, Economic Development
7. Refrigerator disposal releases ozone-depleting chemicals
8. Researchers developing new arsenal in war against cancer
9. The growing Staphylococcus aureus arsenal
10. Tiny molecules have big potential as cancer drugs, Stanford researcher believes
11. New and better drugs for tuberculosis goal of UH professor

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Economic realities depleting arsenal antiparasitic drugs

(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
(Date:5/20/2013)... planning grant will help establish the Center for Advanced ... University of Illinois at Urbana-Champaign and Worcester Polytechnic Institute ... to research in drying moist, porous materials such as ... chemical products; textiles; and biopharmaceuticals," said Hao Feng, a ... nutrition and the Illinois site director. , According to ...
(Date:5/19/2013)... men and women of European descent inherit common foot ... deformities, including hammer or claw toe. Findings from the ... foot disorders in humansappear in Arthritis Care & ... of the American College of Rheumatology (ACR). , ... older adults have foot disorders which may limit mobility ...
Breaking Biology News(10 mins):U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2Blame your parents for bunion woes 2
(Date:5/20/2013)... Oven Industries Inc. announces a new ... 5R6-900 benchtop controller has many outstanding user-friendly benefits. Contained ... into the wall as a self-contained temperature control system, ... makes the device unique, as well as highly convenient ... can also be used universally, which allows the user ...
(Date:5/20/2013)... , May 20, 2013  (PSHR) Pacific Shore ... based products across a broad range of product ... retained investor relations firm, BlueWater Advisory Group, to ... to trading process, and to direct the company,s ... Matthew Mills , ...
(Date:5/20/2013)... With bed bugs' presence come problems in various terms. ... to be eliminated, one must make sure that the bed ... so to help bed bug sufferers get that done, it ... bugs without using harmful pesticides. In it, the company ... Bug Bully. , According to My Cleaning Products, contrary to ...
(Date:5/20/2013)... 2013   Flexion Therapeutics , Inc. today announced ... to its management team as chief financial officer. ... management experience with biotechnology and medical device companies. ... financial officer for Novavax (NASDAQ: NVAX ) ... $250 million through a combination of investment funding and ...
Breaking Biology Technology:New Laboratory Temperature Controller by Oven Industries 2Pacific Shore Holdings Retains Investor Relations Firm 2New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products 2Flexion Therapeutics Names Frederick Driscoll Chief Financial Officer 2
Cached News: